Treatment Innovations
Innovations in cancer treatment are transforming patient care by introducing more precise, effective, and less invasive therapies. Immunotherapy, including checkpoint inhibitors and CAR-T cell therapy, has revolutionized cancer care by harnessing the immune system to target and destroy cancer cells.
BeiGene wins US nod for Tevimbra label expansion (BGNE:NASDAQ) | Seeking Alpha
BeiGene (BGNE) has received U.S. FDA approval for its cancer drug Tevimbra in combination with chemotherapy for certain gastric carcinoma. Read more here.
Glass of milk a day cuts bowel cancer risk – study – BBC News
Dark leafy greens, bread and non-dairy milks containing calcium were also found to offer protection.
Chimerix files FDA application for brain cancer treatment – Triangle Business Journal
The Durham company is seeking a fast track to regulatory approval for its brain cancer treatment.
FDA sets priority review date for Verastem Oncology’s new ovarian cancer drug – Boston Business Journal
The FDA is aiming to make a decision about the treatment before the end of June.
Francis Medical raises $80 million for device that treats prostate cancer – Minneapolis / St. Paul Business Journal
The Maple Grove-based company, spun off from the former NxThera Inc., plans to use proceeds from the round to fund a clinical trial of its Vanquish device in the treatment of prostate cancer.
Amgen Lumakras cleared for colorectal cancer (AMGN:NASDAQ) | Seeking Alpha
Amgen (AMGN) stock in focus as U.S. approval for its lung cancer drug expands for metastatic colorectal cancer. Read more here.
FDA Approves Datroway for Pretreated Advanced Breast Cancer
In trial, datopotamab deruxtecan increased progression-free survival by 2 months
Protein CD74 can predict immunotherapy response in bowel cancer, independent of subtype
Bowel cancer is the fourth most common cancer in the UK, and the second most common cause of cancer death. The disease falls into two types: one where proteins that repair errors in DNA are missing or deficient (the deficient subtype), and one where this machinery is intact (the proficient subtype).
Press release for research from the 2024 ASTRO Annual Meeting
IMRT and proton therapy offer equally high quality of life and tumor control for people with prostate cancer – American Society for Radiation Oncology (ASTRO)
Nanoparticle Therapy Offers New Hope for Prostate Cancer Patients | University of Virginia School of Engineering and Applied Science
Prostate cancer is the second leading cause of cancer death among American men.
Zai Lab stock rises on Tivdak trial data (ZLAB:NASDAQ) | Seeking Alpha
Zai Lab (ZLAB) stock rose after positive trial data for its cervical cancer drug Tivdak and its plans to seek marketing approval for the drug in China. Read more here.
A tiny anticancer weapon: Nano-sized particles trigger tumor cell self-destruction
A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
New hope for treating blood cancers using a breast cancer drug
Two recent studies from researchers at Washington University School of Medicine in St. Louis have identified a promising way to treat certain blood cancers using a drug originally developed for breast cancer. These findings could potentially change how doctors approach the treatment of these challenging diseases. The studies focused on a group of blood cancers […]
Bayers posts Phase 3 win for hot flashes drug (BAYRY:) (BAYRY) | Seeking Alpha
Bayer (BAYZF) (BAYRY) says elinzanetant, its experimental therapy for hot flashes, reached the main goals in a late-stage trial. Read more here.
AI increases chances to detect breast cancer, study finds
Researchers have indicated the use of AI in breast cancer screening increases the chances of detecting the disease. There have been claims that AI could Researchers have indicated the use of AI in breast cancer screening increases
Mersana stock falls after cancer drug data (MRSN:NASDAQ) | Seeking Alpha
Mersana Therapeutics (MRSN) stock hits a 52-week low in reaction to early clinical results for its cancer drug Emi-Le in solid tumors. Read more here.
New drug combo offers hope for liver cancer patients
Researchers at Mount Sinai have achieved a significant breakthrough in treating hepatocellular carcinoma (HCC), the most common type of liver cancer. Led by Dr. Josep M. Llovet, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, the team tested a combination of treatments that could help patients live longer without their cancer […]
Drug breakthrough offers hope for advanced prostate cancer patients | The Independent
Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone therapy enzalutamide.
Toxic glass kills 99% of bone cancer without harming healthy cells
Scientists have demonstrated a new potential treatment for bone cancer. A bioactive glass laced with a toxic metal was able to kill up to 99% of the cancer without harming healthy cells, and could even help regrow healthy bone after.
We Spoke To A Colorectal Cancer Doctor Who Shared 5 Things We Should All Stop Doing Immediately
Cases of colorectal cancer have been rapidly increasing among young adults, so we spoke to a doctor to get some helpful tips.
World’s first cream to treat skin cancer edges closer to reality
Researchers are developing the world’s first topical cream to prevent and treat skin cancer, especially for organ transplant recipients.
Study identifies potential microRNA target to overcome breast cancer resistance
A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes. The research was recently published in the journal Cancers.
Tel Aviv University researchers develop new cancer-fighting system – study
The researchers developed nanoparticles, which dissolve into water and carbon dioxide within a month, to encapsulate two different cancer- fighting drugs.
Study: Nearly Six Million Cancer Deaths Prevented Due to Prevention, Screenings
When it comes to surviving a cancer diagnosis, early detection is key to increasing your chances of survival.
